Achromobacter xylosoxidans in idiopathic cystic bronchiectasis

Anthony Simon Bates* (Corresponding Author), Manjula Natarajan, Raja Vongala Reddy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.

Original languageEnglish
Article numbere211610
JournalBMJ Case Reports
Issue number1
Early online date28 Nov 2018
Publication statusPublished - Nov 2018

Bibliographical note

© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.


  • Achromobacter denitrificans
  • Aged
  • Anti-Bacterial Agents/administration & dosage
  • Bronchiectasis/drug therapy
  • Gram-Negative Bacterial Infections/drug therapy
  • Humans
  • Male


Dive into the research topics of 'Achromobacter xylosoxidans in idiopathic cystic bronchiectasis'. Together they form a unique fingerprint.

Cite this